Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Outstanding Awards and Exercises (Details)

v3.22.4
Stock-Based Compensation - Outstanding Awards and Exercises (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Awards      
Compensation cost not yet recognized      
Unrecognized compensation cost options $ 41    
Period over which unrecognized compensation cost will be recognized 1 year 1 month 6 days    
Awards | Series A common stock      
Options      
Outstanding ending balance (in shares) 0    
Awards | Series C common stock      
Options      
Outstanding beginning balance (in shares) 3,483    
Options granted (in shares) 172    
Exercised (in shares) (53)    
Outstanding ending balance (in shares) 3,602 3,483  
Number of awards exercisable (in shares) 2,412    
WAEP      
WAEP Outstanding beginning balance (in dollars per share) $ 96.61    
WAEP Options granted (in dollars per share) 128.15    
WAEP options exercised (in dollars per share) 62.51    
WAEP Outstanding ending balance (in dollars per share) 98.62 $ 96.61  
WAEP options exercisable (in dollars per share) $ 76.78    
Options additional disclosures      
Weighted average remaining contractual life outstanding 3 years 4 months 24 days    
Weighted average remaining contractual life exercisable 2 years 9 months 18 days    
Aggregate intrinsic value outstanding $ 43    
Aggregate intrinsic value exercisable $ 43    
Awards | Series B and Series C common stock      
Compensation cost not yet recognized      
Shares reserved for future issuance upon exercise of stock options 4,000    
Options      
Options additional disclosures      
Aggregate intrinsic value of options exercised during period $ 3 $ 27 $ 1
Options | Series A common stock      
Options      
Options granted (in shares) 0 0 0
Options | Series B common stock      
Options      
Options granted (in shares) 0 0 0
Options | CEO | Series B common stock      
Options      
Exercised (in shares) (37) (370)  
Outstanding ending balance (in shares) 315    
WAEP      
WAEP options exercised (in dollars per share) $ 97.21    
WAEP Outstanding ending balance (in dollars per share) $ 96.25    
Options additional disclosures      
Weighted average remaining contractual life outstanding 1 year 4 months 24 days    
Aggregate intrinsic value outstanding $ 0    
Options | CEO | Series C common stock      
Options      
Options granted (in shares) 136 167 389